Skip to main content

Table 1 Characteristics of 121 patients with invasive ovarian carcinomas

From: An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas

Parameter

All cases (%)

Age at surgery (years)

 

< 60

73 (60.3)

≥ 60

48 (39.7)

Histological type

 

serous

80 (66.1)

non-serous

29 (24.0)

undifferentiated

12 (9.9)

FIGO stage

 

I

18 (14.9)

II

10 (8.3)

III

84 (69.4)

IV

9 (7.4)

Tumor stage

 

pT1

21 (17.3)

pT2

12 (10.0)

pT3

88 (72.7)

Nodal stage (n = 96)

 

pN0

46 (47.9)

pN1

50 (52.1)

Tumor grade (Silverberg)

 

G1

19 (15.7)

G2

50 (41.3)

G3

52 (43.0)

Intraoperative residual tumor (n = 88)

 

residual tumor < 2 cm

78 (88.6)

residual tumor ≥ 2 cm

10 (11.4)

Chemotherapy (n = 113)

 

Platinum-based

106 (93.8)

non-platinum

3 (2.7)

no chemotherapy

4 (3.5)